Delivery Order SPE2DB24D2100-SPE2DB25FBEQA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $2,032.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,802.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,256.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on May 23, 2025, with a completion date of May 27, 2025. This non-set-aside competitive award was placed for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,456.01 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100s) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,066.33 with a firm fixed price structure. The award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order executed under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.64 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) on September 5, 2025, with completion expected by September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,242.26 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (quantity: 100s) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count bottles) valued at $2,559.11, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEQADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,962.43 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on June 6, 2025, with a completion date of June 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The company's portfolio of federal contracts demonstrates capability across multiple therapeutic domains, and this particular order represents one of numerous delivery orders fulfilling the Defense Health Agency's ongoing pharmaceutical supply requirements for controlled and regulated medications necessary for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/6/25 |